Provided by Tiger Fintech (Singapore) Pte. Ltd.

Alpha Tau Medical

3.93
+0.15003.97%
Post-market: 3.930.00000.00%16:10 EDT
Volume:21.08K
Turnover:81.46K
Market Cap:334.22M
PE:-8.12
High:4.25
Open:3.80
Low:3.79
Close:3.78
52wk High:4.69
52wk Low:2.12
Shares:85.04M
Float Shares:57.13M
Volume Ratio:0.28
T/O Rate:0.04%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.4839
EPS(LYR):-0.4540
ROE:-43.83%
ROA:-22.66%
PB:3.86
PE(LYR):-8.66

Loading ...

Company Profile

Company Name:
Alpha Tau Medical
Exchange:
NASDAQ
Establishment Date:
- -
Employees:
125
Office Location:
Kiryat HaMada St. 5,Jerusalem,Israel
Zip Code:
9777605
Fax:
- -
Introduction:
Alpha Tau Medical Ltd., a clinical-stage oncology therapeutics company, engages in research, development, and commercialization of diffusing alpha-emitters radiation therapy (Alpha DaRT) for the treatment of solid cancer In Israel and the United States. The company's Alpha-DaRT technology is in clinical trials for various forms comprising skin, oral, pancreatic, prostate, lung, liver, and breast cancers; preclinical or pending clinical studies for brain and other cancers; and preclinical studies for hepatic cell carcinoma, glioblastoma multiforme, lung cancer, and others. Alpha Tau Medical Ltd. was incorporated in 2015 and is headquartered in Jerusalem, Israel.